References
- Oxenham H, Bloomfield P, Wheatley DJ, Lee RJ, Cunningham J, Prescott RJ, . Twenty year comparison of a Bjork-Shiley mechanical heart valve with porcine bioprostheses. Heart. 2003;89:715–21.
- Hammermeister K, Sethi GK, Henderson WG, Grover FL, Oprian C, Rahimtoola SH. Outcomes 15 years after valve replacement with a mechanical versus a bioprosthetic valve: Final report of the Veterans Affairs randomized trial. J Am Coll Cardiol. 2000;36:1152–8.
- Hanania G, Michel PL, Montely JM, Warembourg H, Nardi O, Leguerrier A. Outcomes 15 years after valve replacement with a mechanical versus a bioprosthetic valve in patients between 60 and 70 years of age. J Am Coll Cardiol. 2002;39(Suppl A):423A.
- Peterseim D, Can Y-Y, Cheruvu S, Landolfo K, Bashore TM, Lowe JE. Longterm outcome after biological versus mechanical aortic valve replacement in 841 patients. J Thorac Cardiovasc Surg. 1999;335:587–9.
- Schelbert EB, Vaughan-Sarrazin MS, Welke KF, Rosenthal GE. Valve type and long-term outcomes after aortic valve replacement in older patients. Heart. 2008;94:1181–8.
- Van Geldorp M, Jamieson E, Kappetein P, Ye J, Fradet GJ, Eijkemans MJ. Patients outcome after aortic valve replacement with a mechanical or biological prosthesis: Weighing lifetime anticoagulant-related event risk against reoperation risk. J Thorac Cardiovasc Surg. 2009;137:881–6.
- Milano A, Guglielmi C, De Carlo M, Di Gregorio O, Borzoni G, Verunelli F, . Valve-related complications in elderly patients with biological and mechanical aortic valves. Ann Thorac Surg. 1998;66:S82–7.
- Hanania G. Which heart valve prosthesis for patients aged between 60 and 70 years? Heart. 2003;89:481–2.
- Palareti G, Leali N, Coccheri S, Poggi M, Manotti C, D'Angelo A. Bleeding complications of oral anticoagulant treatment: An inception-cohort, prospective collaborative study. Lancet. 1996;348:423–8.
- Birkmeyer N, Birkmeyer JD, Tosteson A, Grunkemeier GL, Marrin C, O'Connor GT. Prosthetic valve type for patients undergoing aortic valve replacement. Ann Thorac Surg. 2000;70:1946–52.
- Bloomfield P. Choice of heart valve prosthesis. Heart. 2002;87:583–9.
- Grunkemeier G, Naftel DC, Starr A, Rahimtoola SH. Long-term performance of heart valve prostheses. Curr Probl Cardiol. 2000;25:73–156.
- Yun KL, Miller DC, Moore KA, Mitchell RS, Oyer PE, Stinson EB. Durability of the Hancock MO bioprosthesis compared with the standard aortic valve bioprosthesis. Ann Thorac Surg. 1995;60:s221–8.
- Brown J, O'Brien S, Wu C, Sikora J, Griffith B, Gammie JS. Isolated aortic valve replacement in North America comprising 108,687 patients in 10 years. Changes in risks, valve types, and outcomes in the Society of Thoracic Surgeons National Database. J Thorac Cardiovasc Surg. 2009;137: 82–90.
- Rahimtoola SH. Choice of prosthetic heart valve in adults. J Am Coll Cardiol. 2010;55:2413–26.
- Edmunds LH Jr, Clark RE, Cohn LH, Miller DC, Weisel RD. Guidelines for reporting morbidity and mortality after cardiac valvular operations. Ann Thorac Surg. 1996;62:932–5.
- Hammar N, Larsen FF, de Faire U. Are geographical differences and time trends in myocardial infarction incidence in Sweden real? Validity of hospital discharge diagnoses. J Clin Epidemiol. 1994;47:685–93.
- Butchart EG, Payne N, Hui-Hua L, Buchan K, Mandana K, Grunkemeier GL. Better anticoagulation control improves survival after valve replacement. J Thorac Cardiovasc Surg. 2002;123:715–23.
- Cannegeiter SC, Rosendaal F, Briet E. Tromboembolic and bleeding complications in patients with mechanical heart valve prostheses. Circulation. 1994;89:635–41.
- Holper K, Wottke M, Lewe T, Baumer L, Meisner H, Paek SU. Bioprosthetic and mechanical valves in the elderly: Benefit and risks. Ann Thorac Surg. 1995;60:S443–6.